18 June 2013
Keywords: rebif, panel, meeting, usa, cancelled, food, drug
Article | 27 December 2001
A US Food and Drug Administration advisory committee meeting to considerthe bid by Switzerland's Serono to get its multiple sclerosis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 December 2001
20 December 2001
7 January 2002
© 2013 thepharmaletter.com